Literature DB >> 23499797

Intermittent hypoxia increases melanoma metastasis to the lung in a mouse model of sleep apnea.

Isaac Almendros1, Josep M Montserrat, Marta Torres, Mireia Dalmases, Maria L Cabañas, Francisco Campos-Rodríguez, Daniel Navajas, Ramon Farré.   

Abstract

Obstructive sleep apnea (OSA) has recently been associated with an increased risk of cancer incidence and mortality in humans. Experimental data in mice have also shown that intermittent hypoxia similar to that observed in OSA patients enhances tumor growth. The aim of this study was to test the hypothesis that intermittent hypoxia mimicking OSA enhances lung metastasis. A total of 75 C57BL/6J male mice (10-week-old) were subjected to either spontaneous or induced melanoma lung metastasis. Normoxic animals breathed room air and intermittent hypoxic animals were subjected to cycles of 20s of 5% O2 followed by 40s of room air for 6h/day. Spontaneous and induced lung metastases were studied after subcutaneous and intravenous injection of B16F10 melanoma cells, respectively. Compared with normoxia, intermittent hypoxia induced a significant increase in melanoma lung metastasis. These animal model results suggest that intermittent hypoxia could contribute to cancer metastasis in patients with OSA.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23499797     DOI: 10.1016/j.resp.2013.03.001

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  50 in total

1.  Treatment of obstructive sleep apnea alters cancer-associated transcriptional signatures in circulating leukocytes.

Authors:  Sina A Gharib; Ashley N Seiger; Amanda L Hayes; Reena Mehra; Sanjay R Patel
Journal:  Sleep       Date:  2014-04-01       Impact factor: 5.849

2.  Here come the sleep apnea-cancer studies.

Authors:  Paul E Peppard; F Javier Nieto
Journal:  Sleep       Date:  2013-10-01       Impact factor: 5.849

3.  Sleep Apnea and Cancer: Analysis of a Nationwide Population Sample.

Authors:  David Gozal; Sandra A Ham; Babak Mokhlesi
Journal:  Sleep       Date:  2016-08-01       Impact factor: 5.849

4.  Obesity, sleep apnea, and cancer.

Authors:  Isaac Almendros; Miguel A Martinez-Garcia; Ramon Farré; David Gozal
Journal:  Int J Obes (Lond)       Date:  2020-02-18       Impact factor: 5.095

Review 5.  Epidemiological aspects of obstructive sleep apnea.

Authors:  John F Garvey; Martino F Pengo; Panagis Drakatos; Brian D Kent
Journal:  J Thorac Dis       Date:  2015-05       Impact factor: 2.895

Review 6.  Emerging co-morbidities of obstructive sleep apnea: cognition, kidney disease, and cancer.

Authors:  Nadia Gildeh; Panagis Drakatos; Sean Higgins; Ivana Rosenzweig; Brian D Kent
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

Review 7.  Intermittent hypoxemia and OSA: implications for comorbidities.

Authors:  Naresh A Dewan; F Javier Nieto; Virend K Somers
Journal:  Chest       Date:  2015-01       Impact factor: 9.410

8.  Obstructive sleep apnea and the prevalence and incidence of cancer.

Authors:  Tetyana Kendzerska; Richard S Leung; Gillian Hawker; George Tomlinson; Andrea S Gershon
Journal:  CMAJ       Date:  2014-08-05       Impact factor: 8.262

9.  Pre-diagnostic Sleep Duration and Sleep Quality in Relation to Subsequent Cancer Survival.

Authors:  Amanda I Phipps; Parveen Bhatti; Marian L Neuhouser; Chu Chen; Tracy E Crane; Candyce H Kroenke; Heather Ochs-Balcom; Michelle Rissling; Beverly M Snively; Marcia L Stefanick; Miriam M Treggiari; Nathaniel F Watson
Journal:  J Clin Sleep Med       Date:  2016-04-15       Impact factor: 4.062

Review 10.  Obstructive sleep apnea promotes cancer development and progression: a concise review.

Authors:  Jie Cao; Jing Feng; Lian Li; Baoyuan Chen
Journal:  Sleep Breath       Date:  2015-02-03       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.